Biotec start-up Newrotex has taken 1,680 sq ft of manufacturing and R&D lab and office space at The Oxford Trust’s Wood Centre for Innovation in Headington.
The relocation marks the next stage in Newrotex’s growth as it expands its team and seeks to strengthen the scalability of its quality and manufacturing systems.
The company joins a host of science and tech occupiers including DJS Antibodies, Helio Display Materials, Jack Fertility, Lumai, Exogene and PicturaBio.
Dr Alex Woods, Newrotex founder and chief executive, said: “This move reflects a strategic shift for Newrotex as we prepare for pivotal clinical studies and market entry. The Wood Centre for Innovation provides the infrastructure and environment we need to scale our manufacturing processes, advance regulatory readiness, and execute our clinical roadmap.
“The combination of high-quality laboratory facilities and a collaborative innovation community will enable us to accelerate our growth and ultimately bring this transformative nerve-repair treatment closer to patients.”
Steve Burgess, chief executive of The Oxford Trust, said: “We are delighted to welcome Newrotex to our Wood Centre for Innovation. Their work in nerve regeneration is truly pioneering and exemplifies the type of science-led innovation the Trust aims to support in our centres.
“With its woodland setting in the heart of the Headington Science Cluster, the centre is home to a thriving community of companies driving breakthroughs across biotech and deeptech.”
Image: The Newrotex team outside its new home. Picture by Ed Nix.
© Thames Tap (powered by ukpropertyforums.com).
This article and its contents are the intellectual property of UK Property Forums and may not be reproduced, distributed, or used in any form without prior written permission. The views expressed are those of the author(s) and do not constitute legal or professional advice.
